Clinical Trial Update: XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan

View source ↗

Summary

Post-marketing surveillance trial update for XIENCE V/PROMUS Everolimus-Eluting Stent System in Japan; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina
• Coronary Artery Disease
• Coronary Artery Stenosis
• Coronary Disease
• Coronary Occlusion
• Coronary Restenosis
• Myocardial Ischemia
• Stent Thrombosis
• Vascular Disease

Drugs mentioned

• Promus (sirolimus-eluting stent)
• XIENCE V (everolimus-eluting stent)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Angina, Chronic Coronary Occlusion | Status: COMPLETED | Results posted: 2018-02-19